Up to $2 million in grant funding may be provided by NIAID to support DARE-HPV development, bringing total non-dilutive funding for DARE-HPV advancement to up to $12 million SAN DIEGO, Feb. 06 ...

But even the surviving institutes won’t be spared cuts: The National Institute of Allergy and Infectious Diseases had a budget of more than $6.5 billion in 2025 but will receive just over $4 ...

She will also be the first woman to lead NIAID, which is the second largest of the NIH’s 27 institutes and centres after the National Cancer Institute, with an annual budget of $6.3 billion (S$8 ...

NORTH BRUNSWICK, N.J., February 03, 2025--Lactiga, a biotech company leading the development of naturally-occurring antibody therapies for inflammatory and immunodeficient conditions, has been ...

The National Institutes of Health on Friday announced six acting directors to run institutes, ... and Jeff Taubenberger to run the National Institute of Allergy and Infectious Diseases. ...

A $1,084,824 Phase II Small Business Innovative Research grant from the National Institute of Allergy and Infectious Diseases, which is part of the National Institutes of Health, awarded the funds ...

A research facility within the US National Institutes of Health that is tasked with studying Ebola and other deadly infectious diseases has been instructed by the Trump administration’s ...

As part of this initiative, the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. National Institutes of Health (NIH), will conduct and sponsor the Phase I first-in ...

Dr. Benjamin Jin, a biologist, works on immunotherapy for HPV+ cancers, in a lab at the National Cancer Institute at the National Institutes of Health (NIH) in Bethesda, Md., in 2018.

Daré Bioscience Announces Funding Award Notice from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Support DARE-HPV Development ...

But even the surviving institutes won’t be spared cuts: The National Institute of Allergy and Infectious Diseases had a budget of more than $6.5 billion in 2025 but will receive just over $4 ...

SAN DIEGO, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in innovation for the health and wellbeing of women, today announced that it received a Notice of Award of a ...